This inventor holds 2 USPTO granted patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2011-2013.
Company Filing History:
Years Active: 2011-2013
Title: Innovations by Inventor Wen-jun Sun
Introduction
Wen-jun Sun is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of plasmid DNA production, holding 2 patents that enhance the efficiency of this process. His work is particularly relevant in the pharmaceutical industry, where high-quality DNA is essential for various medical applications.
Latest Patents
Wen-jun Sun's latest patents focus on methods for increasing the yield of plasmid DNA production. The first patent describes a method that involves selecting a highly productive clonal subtype of a strain, including but not limited to the DH5 strain, which harbors a DNA plasmid. This clonal subtype is cultivated using fed-batch fermentation in a chemically-defined medium. The process can generate record quantities of plasmid DNA when cultivated on an industrial scale. This method is particularly useful for producing pharmaceutical-grade DNA for polynucleotide vaccination and gene therapy treatment regimens.
Career Highlights
Wen-jun Sun is currently associated with Merck Sharp & Dohme Corporation, where he applies his expertise in biotechnology and genetic engineering. His innovative approaches have contributed to advancements in the production of plasmid DNA, which is crucial for modern medical treatments.
Collaborations
Some of his notable coworkers include Michel M Chartrain and Laura Kizer Bentley, who have collaborated with him on various projects within the company.
Conclusion
Wen-jun Sun's work in plasmid DNA production exemplifies the impact of innovation in biotechnology. His patents not only advance scientific knowledge but also hold significant potential for improving medical treatments.